Eris Lifesciences Limited — Others, 25-07-2025: Shareholders meeting

The company's 19th Annual General Meeting addressed crucial operational and governance matters. Shareholders approved the audited standalone and consolidated financial statements for the fiscal year ending March 31, 2025. Key appointments included M/s. Walker Chandiok & Co. LLP as Statutory Auditor and M/s. Ravi Kapoor & Associates as Secretarial Auditor, both for a five-year term. The remuneration for Cost Auditors for the upcoming fiscal year was also ratified. Additionally, Mr. Amit Bakshi was re-appointed as Managing Director, along with Mr. Inderjeet Singh Negi and Mr. Kaushal Kamlesh Shah as Whole-Time Directors, ensuring continued leadership.